Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Zattoni

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
Central European Journal of Urology|March 21, 2025
Role of PARP inhibitors in prostate cancerJulia Szczotka, Gabriela Szpila, Michał Hejduk, et al.
Frontiers in Surgery|July 29, 2021
Focal Therapy for Prostate Cancer: Complications and Their TreatmentArnas Rakauskas, Giancarlo Marra, Isabel Heidegger, et al.
Frontiers in Surgery|July 26, 2021
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?Fabio Zattoni, Isabel Heidegger, Veeru Kasivisvanathan, et al.
Cancers|April 26, 2025
Adrenalectomy Performed with the Da Vinci Single-Port Robotic System: A Systematic Review and Pooled AnalysisGiuseppe Reitano, Arianna Tumminello, Carlo Prevato, et al.
World Journal of Urology|April 20, 2023
Role of targeted biopsy, perilesional biopsy, and random biopsy in prostate cancer diagnosis by mpMRI/transrectal ultrasonography fusion biopsyGiacomo Novara, Fabio Zattoni, Giovanni Zecchini, et al.
World Journal of Urology|March 12, 2026
The utility of pelvic lymph node dissection in PSMA-PET negative intermediate and high-risk prostate cancer patients undergoing radical prostatectomyGiuseppe Reitano, R Jeffrey Karnes, Giacomo Novara, et al.
Abdominal Radiology (New York)|January 6, 2018
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter studyFabio Zattoni, Elena Incerti, Michele Colicchia, et al.
Cancers|May 30, 2019
<sup>18</sup>F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective StudyFabio Zattoni, Elena Incerti, Fabrizio Dal Moro, et al.
The Journal of Liquid Biopsy|July 3, 2025
Blood and urine-based biomarkers in prostate cancer: Current advances, clinical applications, and future directionsFelice Crocetto, Michele Musone, Stefano Chianese, et al.
World Journal of Urology|December 19, 2022
Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysisClaudia Kesch, Vlad Pantea, Timo Soeterik, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Central European Journal of Urology|March 21, 2025
Role of PARP inhibitors in prostate cancerJulia Szczotka, Gabriela Szpila, Michał Hejduk, et al.
Frontiers in Surgery|July 29, 2021
Focal Therapy for Prostate Cancer: Complications and Their TreatmentArnas Rakauskas, Giancarlo Marra, Isabel Heidegger, et al.
Frontiers in Surgery|July 26, 2021
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?Fabio Zattoni, Isabel Heidegger, Veeru Kasivisvanathan, et al.
Cancers|April 26, 2025
Adrenalectomy Performed with the Da Vinci Single-Port Robotic System: A Systematic Review and Pooled AnalysisGiuseppe Reitano, Arianna Tumminello, Carlo Prevato, et al.
World Journal of Urology|April 20, 2023
Role of targeted biopsy, perilesional biopsy, and random biopsy in prostate cancer diagnosis by mpMRI/transrectal ultrasonography fusion biopsyGiacomo Novara, Fabio Zattoni, Giovanni Zecchini, et al.
World Journal of Urology|March 12, 2026
The utility of pelvic lymph node dissection in PSMA-PET negative intermediate and high-risk prostate cancer patients undergoing radical prostatectomyGiuseppe Reitano, R Jeffrey Karnes, Giacomo Novara, et al.
Abdominal Radiology (New York)|January 6, 2018
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter studyFabio Zattoni, Elena Incerti, Michele Colicchia, et al.
Cancers|May 30, 2019
<sup>18</sup>F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective StudyFabio Zattoni, Elena Incerti, Fabrizio Dal Moro, et al.
The Journal of Liquid Biopsy|July 3, 2025
Blood and urine-based biomarkers in prostate cancer: Current advances, clinical applications, and future directionsFelice Crocetto, Michele Musone, Stefano Chianese, et al.
World Journal of Urology|December 19, 2022
Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysisClaudia Kesch, Vlad Pantea, Timo Soeterik, et al.
Pageof 16